Login

Consolidated Balance Sheets

In USD, except per-share amounts
Q3 FY2015
As of Sep 30, 2015
Q2 FY2015
As of Jun 30, 2015
Q1 FY2015
As of Mar 31, 2015
Q4 FY2014
As of Dec 31, 2014
Q3 FY2014
As of Sep 30, 2014
Q1 FY2014
As of Mar 31, 2014
Q2 FY2014
As of Jun 30, 2014
Q4 FY2013
As of Dec 31, 2013
Q3 FY2013
As of Sep 30, 2013
Q2 FY2013
As of Jun 30, 2013
Q3 FY2012
As of Sep 30, 2012
Q1 FY2012
As of Mar 31, 2012
Q2 FY2012
As of Jun 30, 2012
Q4 FY2011
As of Dec 31, 2011
Q3 FY2011
As of Sep 30, 2011
Q2 FY2011
As of Jun 30, 2011
ASSETS
Current Assets
Cash and equivalents
Accounts receivable
Prepaid expenses
Total Current Assets
Other Assets
Intellectual Property, (less accumulated amortization of $29,730)
Total Other Assets
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS' DEFICIT
Liabilities
Current Liabilities
Bank overdraft
Accounts payable and accrued expenses
Accrued interest
Convertible notes payable, net of discount of $184,614 (2014 - $0)
Derivative liability
Due to related parties
Line of credit - related party
Advances from officer
Loans payable
Advances from shareholder
Total Liabilities
Stockholders' Deficit
Preferred Stock Authorized: 100,000,000 preferred shares.10,000 shares Series A, issued and outstanding at September 30, 2015 and -0- at December 31, 2014
Common Stock, 900,000,000 shares of common stock with par value of $.0001; 424,944,363 shares of common stock issued and outstanding at September 30, 2015 and (98,226,850) - December 31, 2014
Additional paid in capital
Accumulated other comprehensive loss
Accumulated deficit
Total Stockholders' Deficit
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support